hemodialysis patient population. This observed difference was
statistically significant (P<0.0001).
-- Patients of varied size, age, vascular access type, and geographic
location are participating in home daily hemodialysis, indicating
its broad applicability.
-- 92% of the U.S. dialysis population resides within 60 miles of a
center offering NxStage home hemodialysis training, and nearly 80%
are within 30 miles. This indicates that geographic barriers to
initiating daily home hemodialysis are being addressed.
-- In July 2008, NxStage elected Jonathan Silverstein, a General Partner
of OrbiMed Advisors, LLC, to its Board of Directors in connection with
the recently announced private placement.
-- In June 2008, Jeff Smith joined the Company as Vice President and
General Manager, Home Market.
For the third quarter of 2008, the Company expects revenue to be in the range of $30 to $32 million. The Company also expects a net loss in the range of $13.5 to $14.5 million or ($0.30) to ($0.32) per share, excluding any accounting impact of its private equity financing, and an Adjusted EBITDA loss in the range of $7.0 to $8.0 million for the third quarter of 2008.
This release contains non-GAAP financial measures, a reconciliation of the Company's non-GAAP financial measures to their most comparable GAAP financial measure is in the exhibits to this press release.
NxStage will also host a conference call at 9:00 a.m. Eastern Time on
Tuesday, August 5, 2008 to discuss its second quarter financial results. To
listen to the conference call, please dial 800-901-5248 (domestic) or
617-786- 4512 (international). The passcode is 34533100. The call will also
be webcast LIVE and can be accessed via the investor relations section of
the website at
|SOURCE NxStage Medical, Inc.|
Copyright©2008 PR Newswire.
All rights reserved